A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/1997
11/04/1997	US5683710 Percutaneous absorption preparation
11/04/1997	US5683709 Poly(benzalkonium salt) as an anti-microbial agent for aqueous drug compositions
11/04/1997	US5683684 Use of sphingolipids in the preparation of a cosmetic or dermopharmaceutical composition protecting the skin and hair against the harmful effects of atmospheric pollution
11/04/1997	US5683677 1,1,1,2-tetrafluoroethane; chlorofluorocarbon-free; self-propelling
11/04/1997	US5683676 Canister containing aerosol formulations containing P134a and particulate medicaments
11/04/1997	US5683675 Method of treating retained pulmonary secretions
11/04/1997	US5683461 Injectable paste
11/04/1997	US5682726 Method for forming and packaging iontophoretic drug delivery patches and the like to increase stability and shelf-life
10/1997
10/30/1997	WO1997040152A1 Glial cell line-derived neurotrophic factor receptor
10/30/1997	WO1997040073A2 BIOLOGICALLY ACTIVE PROTEIN (COLLAGEN FRAGMENT HF-COLL-18/514cf) FOR INHIBITING THE GROWTH OF TUMOURS AND CAPILLARY PROFILERATIONS
10/30/1997	WO1997039831A1 Two-chamber cartridge for propellant-free metered aerosols
10/30/1997	WO1997039788A1 Secondary shaping of ionically cross-linked polymer compositions for medical devices
10/30/1997	WO1997039770A1 New pharmaceutical formulation of a thrombin inhibitor for parenteral use
10/30/1997	WO1997039768A1 A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent
10/30/1997	WO1997039762A1 Stabilized antihepatitis-b vaccine tablets
10/30/1997	WO1997039758A1 Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
10/30/1997	WO1997039755A1 Oral pharmaceutical preparation containing ibandronat
10/30/1997	WO1997039752A1 Sertindole preparation and process for the production thereof
10/30/1997	WO1997039747A1 Taste masked paracetamol compositions
10/30/1997	WO1997039746A1 Method of and composition for treating disorders of the skin using vitamin k
10/30/1997	WO1997039745A1 Use of inhaled retinoids in the prevention of cancer
10/30/1997	WO1997039744A1 Immediate release ph-independent solid dosage form of cisapride
10/30/1997	WO1997039743A1 Transdermal contraceptive delivery system
10/30/1997	WO1997039742A1 Transdermally administered dextromethorphan as antitussive agent
10/30/1997	WO1997039741A1 Transdermally administered acetylcysteine as mucolytic agent
10/30/1997	WO1997039740A1 Patch containing 1,2-ethanediol derivatives or salts thereof
10/30/1997	WO1997039739A2 Polyol composition
10/30/1997	WO1997039738A2 Sustained release ionic conjugate
10/30/1997	WO1997039735A1 Improved masking of liposomes from res recognition
10/30/1997	WO1997039731A1 Use of lactic acid esters
10/30/1997	WO1997039698A1 Slow-release, self-absorbing, drug delivery system
10/30/1997	WO1997039632A1 Natural antioxidant composition
10/30/1997	DE19713141A1 Transdermal plaster
10/30/1997	DE19708803A1 Controlling weight of granular products in multiple dispensing machines
10/30/1997	DE19708557A1 Powder medicine capsule dosing and filling machine
10/30/1997	CA2285184A1 Stabilized antihepatitis-b vaccine tablets
10/30/1997	CA2252826A1 Sustained release ionic conjugate
10/30/1997	CA2250529A1 Improved masking of liposomes from res recognition
10/29/1997	EP0803254A1 Alcoholic solutions containing acetylsalicylic acid for percutaneous administration, their use in antithrombotic therapy and medicaments
10/29/1997	EP0803253A1 Matrix-type oral sustained-release tablets containing tianeptine sodium salt
10/29/1997	EP0803251A1 Immediate release pH-independent solid dosage form of cisapride
10/29/1997	EP0803250A1 Controlled release of steroids from sugar coatings
10/29/1997	EP0803249A2 Cholesterol lowering drink mix compositions
10/29/1997	EP0803192A1 Antimycotic ectoparasiticidal product for external use
10/29/1997	EP0802985A1 Cell cycle regulated repressor and dna element
10/29/1997	EP0802976A2 Stabilized external guide sequences
10/29/1997	EP0802911A1 Hydrophobic taxane derivatives
10/29/1997	EP0802807A1 Method of altering composition of nutritional product
10/29/1997	EP0802800A2 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
10/29/1997	EP0802796A1 Chicken anaemia agent broiler vaccine
10/29/1997	EP0802794A1 Modulators of pneumococcal adherence to pulmonary and vascular cells and diagnostic and therapeutic applications
10/29/1997	EP0802790A1 Transdermal therapeutic system for dispensing (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole or one of its pharmaceutically acceptable salts
10/29/1997	EP0802789A1 Plaster containing estradiol
10/29/1997	EP0802788A1 Novel therapeutic delivery systems
10/29/1997	EP0802787A1 In situ gel-forming delivery vehicle for bio-affecting substances, and method of use
10/29/1997	EP0802784A1 Nutrient medium for use as a culture medium for epidermal cells, and uses thereof
10/29/1997	EP0802782A1 Prophylactic and therapeutic treatment of skin sensitization and irritation
10/29/1997	EP0802779A1 Method of producing lenticular tablets by melt calendering
10/29/1997	EP0802737A1 Dietary supplement based on soluble dietary fibers
10/29/1997	EP0802731A1 Prophylactic treatment of allergic contact dermatitis
10/29/1997	EP0773229B1 Cyclodextrin derivatives and their use, especially in cosmetics
10/29/1997	EP0759744A4 Narcotic containing aerosol formulation
10/29/1997	EP0679154B1 New crystalline form of a vitamin d analogue
10/29/1997	EP0639069B1 Galenic form for ocular administration and process for the preparation of same
10/29/1997	EP0637976B1 Medicament for disinfection of the oral cavity
10/29/1997	EP0493380B1 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs
10/29/1997	CN1163575A Immunogenic compositions
10/29/1997	CN1163564A Enterogenin pharmaceutical form
10/29/1997	CN1163563A Liposome composition containing selegilin
10/29/1997	CN1163144A Chinese drug liquid for curing chilblain and scabies
10/29/1997	CN1163133A Spray and nose liniment for preventing and curing common cold and its preparing method
10/29/1997	CN1163132A Oral liquor for giving up drug
10/29/1997	CN1163131A Fengdan oral liquid and its preparation process
10/29/1997	CN1163129A Holographic recovery liquid for tumour patient
10/29/1997	CN1163126A Drug for curing icterohepatitis and cholecystitis
10/29/1997	CN1163124A Decoction for curing cerebral vasscular diseases and its producing method
10/29/1997	CN1163118A Chinese drug preparation for curing diseases of cardio-cerebral vascular system
10/29/1997	CN1163116A Compound health medicinal emblic tablet and its producing technology
10/29/1997	CN1163115A External application medicine for phlebitis
10/29/1997	CN1163114A Ointment for activating vital energy and promoting blood circulation
10/29/1997	CN1163109A Phlebitis powder
10/29/1997	CN1163107A Therapeutic liquid for obstinate tinea
10/29/1997	CN1163106A High efficiency anti-inflammatory and antipruritic ointment and its producing method
10/29/1997	CN1163103A Controlled releasing of steroid from sugarcoating
10/29/1997	CN1163102A Container with freeze-dried vaccine component
10/28/1997	US5681855 Prostaglandin e emulsion
10/28/1997	US5681849 Pharmaceutical composition for topical applications
10/28/1997	US5681846 Extended stability formulations for paclitaxel
10/28/1997	US5681827 Aqueous pourable liquid containing low viscosity sodium alginate, potassium bicarbonate
10/28/1997	US5681822 Shelf stable solutions of cladribine in benzyl alcohol
10/28/1997	US5681814 Formulated IGF-I Composition
10/28/1997	US5681811 Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
10/28/1997	US5681606 Method of preparing a water-based beverage
10/28/1997	US5681590 Dry mix formulation for bisphosphonic acids
10/28/1997	US5681589 Anticancer agents
10/28/1997	US5681588 Delayed release microtablet of β-phenylpropiophenone derivatives
10/28/1997	US5681585 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
10/28/1997	US5681584 Controlled release drug delivery device
10/28/1997	US5681583 Multilayered controlled-release oral solid pharmaceutical forms
10/28/1997	US5681582 Extended release, film-coated tablet of astemizole and pseudoephedrine

1 ... 2629 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 2645 2646 2647 2648 2649 ... 2991